Literature DB >> 1776799

[Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].

J M Guy1, X André-Fouet, J Porte, M Bertrand, M Lamaud, H Verneyre.   

Abstract

Following a case of torsades de pointe (TDP) after the injection of droperidol (D), the authors studied the electrocardiographic variations caused by the drug. Fifty five unselected patients under the same conditions (general anesthesia) were given D (0.25 mg/kg IV). Significant prolongation of the QT interval was seen in 70% of cases by the end of the first minute. QT interval and the ratio of QTm (measured) over QTt increased from 387 +/- 34 ms to 423 +/- 37 ms (p less than 0.0001) and from 1.06 +/- 0.08 to 1.28 +/- 0.1 (p less than 0.001) respectively. These changes could favourise the onset of TDP. Although exceptional in terms of the extensive use of the neuroleptic in question, this possibility indicates the need for monitoring of the duration of QT before and during treatment with droperidol and for prescription of the drug to be avoided in circumstances known to be propitious to this arrhythmia (bradycardia, hypokalemia, anti-arrhythmic drugs).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776799

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  7 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

Review 2.  Systemic antifungal agents. Drug interactions of clinical significance.

Authors:  E Albengres; H Le Louët; J P Tillement
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 3.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting.

Authors:  James K Jewer; Michael J Wong; Sally J Bird; Ashraf S Habib; Robin Parker; Ronald B George
Journal:  Cochrane Database Syst Rev       Date:  2019-03-29

5.  The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.

Authors:  Jon B Cole; Samantha C Lee; Marc L Martel; Stephen W Smith; Michelle H Biros; James R Miner
Journal:  West J Emerg Med       Date:  2020-07-02

6.  Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach.

Authors:  Leonardo Baldaçara; Alexandre P Diaz; Verônica Leite; Lucas A Pereira; Roberto M Dos Santos; Vicente de P Gomes Júnior; Elie L B Calfat; Flávia Ismael; Cintia A M Périco; Deisy M Porto; Carlos E K Zacharias; Quirino Cordeiro; Antônio Geraldo da Silva; Teng C Tung
Journal:  Braz J Psychiatry       Date:  2019-03-07       Impact factor: 2.697

7.  High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings.

Authors:  Leonie Calver; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.